Cocrystal Pharma, Inc. (COCP) NASDAQ
1.02
+0.01(+0.99%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.02
+0.01(+0.99%)
Currency In USD
| Market Cap | 11.05M |
| Enterprise Value | 5.53M |
| P/E Ratio | -1.59 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 46.46 |
| Price/Book Ratio | 3.42 |
| Enterprise/Revenue | 31.97 |
| Enterprise/EBITDA | -0.84 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -39.24 |
| Operating Margin | -40.15 |
| Return On Assets | -1.19 |
| Return On Equity | -1.51 |
| Revenue | 0 |
| Revenue/Share | 0.02 |
| Gross Profit | 0 |
| EBITDA | -8.64M |
| Net Income | -8.83M |
| Diluted EPS | -0.78 |
| Total Cash | 4.68M |
| Total Cash/Share | 0.34 |
| Total Debt | 1.42M |
| Total Debt/Equity | 0.35 |
| Current Ratio | 2.66 |
| Book Value Per Share | 0.3 |
| 52-Week Change | -38.18 |
| 52-Week High | 2.67 |
| 52-Week Low | 0.86 |
| Moving Average 50 Days | 1.28 |
| Moving Average 200 Days | 1.16 |
| Average Volume | 2.42M |
| Shares Outstanding | 10.25M |
| % Held by Institutions | 6.88 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | October 11, 2022 |